CMR Surgical raids FTSE for CFO to help drive growth
CMR Surgical, the Cambridge startup developing a next-generation surgical robot, has attracted an FD from a FTSE giant as chief financial officer to help build the company’s global credentials as it heads to commercialisation.
Ingeborg Øie, who takes up the CFO role on February 25, joins CMR from Smith & Nephew, the FTSE 100 global medical technology business, where she was most recently finance director of Canada and previously VP Global Investor Relations in the corporate headquarters since 2014.
Ingeborg has significant experience in the medical devices sector having started her career as a medical devices analyst at Goldman Sachs and later becoming managing director and head of medical devices and healthcare services coverage at Jefferies International.She is currently a non-executive director of Georgia Healthcare Group PLC, the London Stock Exchange main market-listed healthcare services group.
Ingeborg holds a MEng in Biomedical Engineering from Imperial College London and an MSc in Public Health from London School of Hygiene and Tropical Medicine. She is a CFA charterholder.
Martin Frost, chief executive officer of CMR Surgical, said: “Ingeborg brings a wealth of experience in the medical devices industry to the board and executive management team.
“She will play an integral role in the rapid growth of CMR Surgical and the commercialisation of Versius worldwide.”
Ingeborg Øie, added: “I am extremely pleased to be joining CMR Surgical and the mission to make minimal access surgery universally accessible and affordable.
“The Versius is one of the world’s most exciting medical technologies and I feel privileged to now be part of the dynamic team of employees and investors who created it, and to contribute to the continued success of the company.”